Patents by Inventor Allen Ebens

Allen Ebens has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110070243
    Abstract: The present invention is directed to compositions of matter useful for the treatment of hematopoietic tumor in mammals and to methods of using those compositions of matter for the same.
    Type: Application
    Filed: September 9, 2010
    Publication date: March 24, 2011
    Inventors: CRAIG CROWLEY, FREDERIC J. DE SAUVAGE, DAN L. EATON, ALLEN EBENS, JR., KRISTI ELKINS, JO-ANNE S. HONGO, JAGATH REDDY JUNUTULA, ANDREW POLSON, SARAJANE ROSS, VICTORIA SMITH, RICHARD L. VANDLEN, BING ZHENG
  • Publication number: 20110042260
    Abstract: The present invention is directed to compositions of matter useful for the treatment of hematopoietic tumor in mammals and to methods of using those compositions of matter for the same.
    Type: Application
    Filed: August 12, 2010
    Publication date: February 24, 2011
    Inventors: Craig Crowley, Frederic J. de Sauvage, Dan L. Eaton, Allen Ebens, JR., Jo-Anne S. Hongo, Andrew Polson, Sarajane Ross, Victoria Smith, Richard L. Vandlen
  • Publication number: 20110045005
    Abstract: The present invention is directed to compositions of matter useful for the treatment of hematopoietic tumor in mammals and to methods of using those compositions of matter for the same.
    Type: Application
    Filed: April 7, 2010
    Publication date: February 24, 2011
    Inventors: Craig Crowley, Frederic J. de Sauvage, Dan L. Eaton, Allen Ebens, JR., Andrew Polson, Victoria Smith
  • Publication number: 20100260748
    Abstract: The present invention is directed to compositions of matter useful for the treatment of hematopoietic tumor in mammals and to methods of using those compositions of matter for the same.
    Type: Application
    Filed: March 31, 2010
    Publication date: October 14, 2010
    Inventors: Kristi Elkins, Andrew Polson, Allen Ebens, Camelia Adams, Bing Zheng, Jagath R. Junutula, Jo-Anne Hongo, Yan Wu
  • Publication number: 20090068178
    Abstract: The present invention is directed to compositions of matter useful for the treatment of hematopoietic tumor in mammals and to methods of using those compositions of matter for the same.
    Type: Application
    Filed: January 31, 2008
    Publication date: March 12, 2009
    Applicant: Genentech, Inc.
    Inventors: Craig Crowley, Frederic J. de Sauvage, Dan L. Eaton, Allen Ebens, JR., Kristi Elkins, Jo-Anne S. Hongo, Jagath Reddy Junutula, Andrew Polson, Sarajane Ross, Victoria Smith, Richard L. Vandlen, Bing Zheng
  • Publication number: 20090053226
    Abstract: The present invention is directed to compositions of matter useful for the treatment of hematopoietic tumor in mammals and to methods of using those compositions of matter for the same.
    Type: Application
    Filed: March 27, 2008
    Publication date: February 26, 2009
    Inventors: Craig Crowley, Frederic J. de Sauvage, Dan L. Eaton, Allen Ebens, JR., Andrew Polson, Victoria Smith
  • Publication number: 20080050310
    Abstract: Anti-CD22 antibodies and immunoconjugates thereof are provided. Methods of using anti-CD22 antibodies and immunoconjugates thereof are provided.
    Type: Application
    Filed: May 29, 2007
    Publication date: February 28, 2008
    Applicant: Genentech, Inc.
    Inventors: Allen Ebens, Alane Gray, Wei-Ching Liang, Yan Wu, Shang-Fan Yu
  • Publication number: 20070269446
    Abstract: The present invention is directed to compositions of matter useful for the treatment of hematopoietic tumor in mammals and to methods of using those compositions of matter for the same.
    Type: Application
    Filed: November 28, 2006
    Publication date: November 22, 2007
    Applicant: Genentech, Inc.
    Inventors: Frederic de Sauvage, Dan Eaton, Allen Ebens, Andrew Polson, Victoria Smith, Suzie Scales
  • Publication number: 20070207142
    Abstract: The present invention is directed to compositions of matter useful for the treatment of hematopoietic tumor in mammals and to methods of using those compositions of matter for the same.
    Type: Application
    Filed: August 3, 2006
    Publication date: September 6, 2007
    Applicant: Genentech, Inc.
    Inventors: Craig Crowley, Frederic de Sauvage, Dan Eaton, Allen Ebens, Jo-Anne Hongo, Andrew Polson, Sarajane Ross, Victoria Smith, Richard Vandlen
  • Publication number: 20060251662
    Abstract: The present invention is directed to compositions of matter useful for the treatment of hematopoietic tumor in mammals and to methods of using those compositions of matter for the same.
    Type: Application
    Filed: May 4, 2006
    Publication date: November 9, 2006
    Inventors: Wesley Chang, Frederic de Sauvage, Dan Eaton, Allen Ebens, Gretchen Frantz, Jo-Anne Hongo, Hartmut Koeppen, Andrew Polson, Victoria Smith
  • Publication number: 20060216232
    Abstract: The present invention is directed to compositions of matter useful for the treatment of hematopoietic tumor in mammals and to methods of using those compositions of matter for the same.
    Type: Application
    Filed: December 21, 2005
    Publication date: September 28, 2006
    Inventors: Wesley Chang, Frederic Sauvage, Dan Eaton, Allen Ebens, Gretchen Frantz, Hartmut Koeppen, Andrew Polson, Victoria Smith
  • Publication number: 20060195938
    Abstract: The instant invention provides nucleic acid molecules encoding insect acetyl CoA carboxylase, as well as acetyl CoA carboxylase encoded thereby. The invention further provides methods of identifying agents that modulate a level of acetyl CoA carboxylase mRNA, polypeptide, or enzyme activity. Such agents are candidate insecticidal compounds.
    Type: Application
    Filed: June 13, 2005
    Publication date: August 31, 2006
    Inventors: Eva-Maria Franken, Gregory Weddell, Stuart Johnston, Lijuan Zhou, Dago Dimster-Denk, Allen Ebens
  • Publication number: 20050276812
    Abstract: The present invention relates to antibody-drug conjugate compounds of Formula I: Ab-(L-D)p??I where one or more maytansinoid drug moieties (D) are covalently linked by L to an antibody (Ab) which binds to an ErbB receptor, or which binds to one or more tumor-associated antigens or cell-surface receptors. These compounds may be used in methods of diagnosis or treatment of cancer, and other diseases and disorders.
    Type: Application
    Filed: May 31, 2005
    Publication date: December 15, 2005
    Applicant: Genentech, Inc.
    Inventors: Allen Ebens, Frederic Jacobson, Paul Polakis, Ralph Schwall, Mark Sliwkowski, Susan Spencer
  • Publication number: 20050238649
    Abstract: Auristatin peptides, including MeVal-Val-Dil-Dap-Norephedrine (MMAE) and MeVal-Val-Dil-Dap-Phe (MMAF), were prepared and attached to Ligands through various linkers, including maleimidocaproyl-val-cit-PAB. The resulting ligand drug conjugates were active in vitro and in vivo.
    Type: Application
    Filed: November 5, 2004
    Publication date: October 27, 2005
    Applicant: Seattle Genetics, Inc.
    Inventors: Svetlana Doronina, Peter Senter, Brian Toki, Allen Ebens, Toni Kline, Paul Polakis, Mark Sliwkowski, Susan Spencer
  • Publication number: 20050238650
    Abstract: The present invention is directed to compositions of matter useful for the treatment of hematopoietic tumor in mammals and to methods of using those compositions of matter for the same.
    Type: Application
    Filed: November 16, 2004
    Publication date: October 27, 2005
    Inventors: Craig Crowley, Frederic de Sauvage, Dan Eaton, Allen Ebens, Andrew Polson, Victoria Smith
  • Publication number: 20050226869
    Abstract: The present invention is directed to compositions of matter useful for the treatment of hematopoietic tumor in mammals and to methods of using those compositions of matter for the same.
    Type: Application
    Filed: December 21, 2004
    Publication date: October 13, 2005
    Inventors: Wesley Chang, Dan Eaton, Allen Ebens, Frederic de Sauvage, Gretchen Frantz, Jo-Anne Hongo, Hartmut Koeppen, Andrew Polson, Victoria Smith
  • Publication number: 20050229265
    Abstract: The present invention provides methods for identifying pesticide targets and pesticidal agents using transposable elements in insects and insect cells lines. The invention provides engineered transposable elements for use in identification of pesticide targets. The invention further provides a biological array, a collection of transgenic insect lines or insect cell lines, the genome of each containing at least one transposable element that mutates one of the insect's genes, such that the complete collection contains a mutation in essentially every gene in the insect's genome.
    Type: Application
    Filed: April 10, 2002
    Publication date: October 13, 2005
    Inventors: Jonathan Margolis, Margaret Winberg, Stephen Thibault, Allen Ebens Jr, Wesley Miyazaki, Casey Kopczynski